Benchmark and data visualization of Canadian public listed companies in the Biotechnology Industry, with top companies, stocks performance comparison, competitive analysis, and comparisons of top companies for market research.
Canada public listed companies in the Biotechnology industry: 29
Canada Biotechnology total companies market cap (USD): $12.91 Billion
Company | Market Cap (USD) | Country | Sector | Industry |
---|---|---|---|---|
Xenon Pharmaceuticals Inc. | $2.73 B | Canada | Healthcare | Biotechnology |
BELLUS Health Inc. |
$1.86 B
(June 1, 2023) |
Canada | Healthcare | Biotechnology |
Trillium Therapeutics Inc. |
$1.82 B
(Nov. 1, 2021) |
Canada | Healthcare | Biotechnology |
Aurinia Pharmaceuticals Inc. |
$1.74 B
(July 1, 2021) |
Canada | Healthcare | Biotechnology |
Sierra Oncology, Inc. |
$1.34 B
(June 1, 2022) |
Canada | Healthcare | Biotechnology |
AbCellera Biologics Inc. | $791.0 M | Canada | Healthcare | Biotechnology |
Zymeworks Inc. | $627.9 M | Canada | Healthcare | Biotechnology |
Fusion Pharmaceuticals Inc. |
$604.2 M
(Jan. 1, 2024) |
Canada | Healthcare | Biotechnology |
ESSA Pharma Inc. | $222.7 M | Canada | Healthcare | Biotechnology |
Cybin, Inc. | $199.1 M | Canada | Healthcare | Biotechnology |
Top 1-year algo backtest: +265.99% - Try Disfold DeepFinance for FREE now!